Position in NVS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$37,000,327
+$2,568,536 QoQ
Shares Held
242,228
-3.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Midwest Trust Co holds $383,258,093 across 12 Drug Manufacturers - General names. NVS ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
485,280 | $105,543,547 | |
| 2 | MRK |
Merck & Co., Inc.
|
747,618 | $89,930,969 | |
| 3 | LLY |
ELI LILLY & Co
|
65,139 | $59,912,898 | |
| 4 | JNJ |
Johnson & Johnson
|
166,891 | $40,794,836 | |
| 5 | NVS |
Novartis AG
This page
|
242,228 | $37,000,327 | |
| 6 | AMGN |
Amgen Inc
|
78,916 | $27,766,594 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
116,266 | $7,051,532 | |
| 8 | GSK |
GSK plc
|
123,256 | $6,802,498 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,000,327 | 242,228 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $34,431,791 | 249,741 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $32,361,620 | 252,352 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $32,296,721 | 266,893 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||